Innovex signs deal to buy TCO Group for $95 million
Innovex International, Inc.
Innovus Pharmaceuticals, Inc.
Innovex International, Inc. INVX | 0.00 | |
Innovus Pharmaceuticals, Inc. INNV | 0.00 |
- Innovex agreed to buy Norway-based TCO Group in a cash-and-stock deal valued at USD 95 million.
- Closing is expected early in the third quarter of 2026.
- TCO posted about USD 12 million net income on about USD 18 million adjusted EBITDA for the year ended Dec. 31, 2025.
- Valuation implies about 5.4x 2025 adjusted EBITDA; the deal is expected to be accretive to EPS.
- TCO, founded in 1999 in Voss, develops intervention-free laminated glass plug technology used in well operations.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovex International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606150731BIZWIRE_USPR_____20260615_BW340119) on June 15, 2026, and is solely responsible for the information contained therein.